Medications

'Magic mushroom' drug edges toward mainstream therapy

(HealthDay)—Tony Head was depressed and fearing death from stage 4 prostate cancer when, as part of a supervised scientific trial, he took a large dose of the psychedelic agent in "magic mushrooms," psilocybin.

Neuroscience

An EEG to assess a baby's developmental risk?

Does exposure to stress early in life affect a baby's brain development, and is there a way to single out babies who might benefit from early intervention? A two-center study led by Boston Children's Hospital, published today ...

Neuroscience

Mindfulness training provides a natural high, study finds

New research from the University of Utah finds that a mindfulness meditation practice can produce a healthy altered state of consciousness in the treatment of individuals with addictive behaviors. Not unlike what one might ...

Oncology & Cancer

Spirituality can promote the health of breast cancer survivors

Throughout her 20-year career as a nurse practitioner, Jennifer Hulett noticed survivors of breast cancer would often express gratitude for being alive and mention God or a divine acknowledgement that had improved their health ...